Expert Review of Vaccines

Papers
(The H4-Index of Expert Review of Vaccines is 32. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Impact of the Delta variant on vaccine efficacy and response strategies180
COVID-19 vaccine hesitancy in South Africa: how can we maximize uptake of COVID-19 vaccines?147
Effects of SARS-CoV-2 variants on vaccine efficacy and response strategies133
COVID-19 vaccine: where are we now and where should we go?110
To mix or not to mix? A rapid systematic review of heterologous prime–boost covid-19 vaccination85
DNA vaccines for SARS-CoV-2: toward third-generation vaccination era78
ExploringKlebsiella pneumoniaecapsule polysaccharide proteins to design multiepitope subunit vaccine to fight against pneumonia77
Nanovaccine: an emerging strategy63
Safety of an inactivated SARS-CoV-2 vaccine among healthcare workers in China63
The emergence of new strains of SARS-CoV-2. What does it mean for COVID-19 vaccines?62
COVID-19 vaccine effectiveness among immunocompromised populations: a targeted literature review of real-world studies61
Parental COVID-19 vaccine hesitancy: a cross-sectional survey in Italy56
COVID-19 vaccines: concerns beyond protective efficacy and safety56
Determinants of parental hesitancy to vaccinate their children against COVID-19 in China55
Transmission-Blocking Vaccines: Harnessing Herd Immunity for Malaria Elimination54
Social media strategies to affect vaccine acceptance: a systematic literature review54
Inhaled vaccine delivery in the combat against respiratory viruses: a 2021 overview of recent developments and implications for COVID-1952
Surveying willingness toward SARS-CoV-2 vaccination of healthcare workers in Italy50
COVID-19 vaccine acceptance and hesitancy among healthcare workers in South Africa48
Global impact of delta plus variant and vaccination48
COVID-19 vaccination in pregnant and lactating women: a systematic review48
CpG-Adjuvanted Hepatitis B Vaccine (HEPLISAV-B®) Update47
From COVID-19 Vaccination Intention to Actual Vaccine Uptake: A Longitudinal Study Among Chinese Adults After Six Months of a National Vaccination Campaign41
Willingness to receive a booster dose of inactivated coronavirus disease 2019 vaccine in Taizhou, China41
Vaccine hesitancy in health-care providers in Western countries: a narrative review37
COVID-19 vaccination hesitancy in pregnant and breastfeeding women and strategies to increase vaccination compliance: a systematic review and meta-analysis37
Efficacy and effectiveness of a 23-valent polysaccharide vaccine against invasive and noninvasive pneumococcal disease and related outcomes: a review of available evidence36
Clinical development and approval of COVID-19 vaccines36
Chlamydia trachomatisvaccines for genital infections: where are we and how far is there to go?36
COVID-19 vaccine equity: a health systems and policy perspective36
From infection to vaccination: reviewing the global burden, history of vaccine development, and recurring challenges in global leishmaniasis protection33
Microneedle Systems for Vaccine Delivery: the story so far33
COVID-19 and vaccination: myths vs science32
COVID-19 vaccination hesitancy in Italian healthcare workers: a systematic review and meta-analysis32
COVID-19 pandemic: SARS-CoV-2 specific vaccines and challenges, protection via BCG trained immunity, and clinical trials32
Expert review on global real-world vaccine effectiveness against SARS-CoV-232
0.68623208999634